Uterine
Paramaters |
Group |
I |
II |
III |
IV |
| Dose |
0 mg/kg |
750 mg/kg |
400 mg/kg |
750 + 400 mg/kg |
20th day
Corrected B. wt |
Mean |
279.62 |
19.53 |
275.73 |
271.9 |
| SD |
28.32 |
5.43 |
13.57 |
32.82 |
| n |
9 |
9 |
8 |
9 |
Relative
Uterus Wt. (%) |
Mean |
19.53 |
17.37 |
19.08 |
19.66 |
| SD |
5.43 |
5.19 |
2.3 |
5.33 |
| n |
9 |
9 |
8 |
9 |
| (% ) Pre Implantation Loss |
Mean |
2.47 |
1.01 |
1.04 |
1.78 |
| SD |
7.41 |
3.03 |
2.95 |
3.54 |
| n |
9 |
9 |
8 |
9 |
| (% ) Post Implantation Loss |
Mean |
1.01 |
4.2 |
9.56 |
6.67 |
| SD |
3.03 |
6.55 |
16.92 |
1.01 |
| n |
9 |
9 |
8 |
3.03 |
| % Live fetuses |
Mean |
98.99 |
95.8 |
90.44 |
93.33 |
| SD |
3.03 |
6.55 |
16.92 |
20.00 |
| n |
9 |
9 |
8 |
9 |
| % Dead Fetuses |
Mean |
0.00 |
0.00 |
0.00 |
0.00 |
| SD |
0.0 |
0.0 |
0.0 |
0.0 |
| n |
9 |
9 |
8 |
9 |
Group I : Control Group II: β Cyclodextrin, III: Tolbutamide IV: β Cyclodextrin + tolbutamide. |